Featured Article

Ken Getz of Tufts CSDD Discusses RBQM Study Conducted with CluePoints and PwC

In part 1 of this video interview series with Ken Getz, executive director and research professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine and Steve Young, chief science officer, CluePoints, Getz touches on the findings from a recent study on RBQM adoption.

Blog
The Bold Future of RBQM for CROs
Blog
Meet SPOT: Transforming Site Monitoring Practices with Adaptive Intelligence
Blog
A New Era of Automation: Improving Efficiency & Outcomes with Intelligent Medical Coding